Revolade (eltrombopag)

pCPA File Number: 20760
Negotiation Status:
Negotiations were not pursued
Indication(s):
Thrombocytopenia associated with chronic hepatitis c infection
Sponsor/Manufacturer:
GlaxoSmithKline
CADTH Project Number:
SR0377
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: